38mon MSN
Beam Therapeutics Inc. (BEAM) reports updated data from BEACON Phase 1/2 Trial of Ristoglogene
Beam Therapeutics Inc. (NASDAQ:BEAM) is among the 12 Best Genomics Stocks to Invest In. TheFly reported on December 2, 2025, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback